After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Quest Diagnostics Inc. convinced a federal appeals court Thursday not to revive a class action that alleged the clinical laboratory improperly shared patients’ data with Meta Platforms Inc.

The telehealth platform expects the new offering to add to its user base as it draws customers looking to prevent future ...

Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the ...

After leading Quest Diagnostics as CEO for more than a decade, Steve Rusckowski will retire from the Secaucus-based company this fall. As part of its leadership succession planning, on Feb. 3, the ...

Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors ...

In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...

SECAUCUS, N.J. and INDIANAPOLIS, Aug. 3, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its ...

SECAUCUS, N.J. and INDIANAPOLIS, June 23, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the formation of a ...

L-R: Quest Diagnostics CEO Steve Rusckowski; Denis Gallagher, vice president of operations for Quest's northeast region, and Marlborough Mayor Arthur Vigeant, were speakers at the grand opening of ...

The private testing lab is ramping up tests at the behest of the government. In the two weeks since Quest Diagnostics began processing novel coronavirus samples in its infectious disease lab, the ...